Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma
Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery did not improve pCR rate and was associated with worse OS and DFS in esophageal squamous cell carcinoma.
Authors
- Jie Jiang (ORCID: https://orcid.org/0000-0002-2739-6995)
- Xiaolei Zhu
- Hongming Liu (ORCID: https://orcid.org/0000-0001-5800-6307)
- Guanzhi Ye (ORCID: https://orcid.org/0000-0002-7279-2567)
- Ning Li (ORCID: https://orcid.org/0000-0001-8650-8603)
- Gaojian Pan
- Guojun Geng
Institutions
- First Affiliated Hospital of Xiamen University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1186/s12876-025-03802-5
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Natural Science Foundation of Fujian Province